1. Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreak
- Author
-
Carlo Resteghini, Paola Maggioni, Vito Di Martino, Lisa Licitra, and on behalf of Head and Neck Cancer Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
- Subjects
medicine.medical_specialty ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,business.industry ,General surgery ,medicine.medical_treatment ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Outbreak ,COVID-19 ,Head neck cancer ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,lcsh:RC254-282 ,Radiation therapy ,Editorial ,medicine ,Head and neck surgery ,Pharmacology (medical) ,business - Abstract
In a time of uncertainties such the present days, we all look for guiding principles. When no guidelines are available, principles shape our actions. Above all, do no harm has been ours as we are facing the largely unknown challenge of the global COVID-19 epidemic. This mentality guided our efforts to strike the balance between reducing exposure of patients and health care providers to risk of infection on the one hand, and on the other, meeting our daily goal of providing optimal oncologic treatment in a tertiary center of national relevance.
- Published
- 2020